Massachusetts Financial Services CO Lantheus Holdings, Inc. Transaction History

Massachusetts Financial Services CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$18.47 - $24.03 $1.81 Million - $2.36 Million	-98,248 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$21.01 - $28.94 $230,857 - $317,992	10,988 Added 12.59%	98,248 $2.46 Million
Q2 2019 Aug 14, 2019	BUY	$23.33 - $28.3 $284,439 - $345,033	12,192 Added 16.24%	87,260 $2.47 Million
Q1 2019 May 13, 2019	BUY	$14.93 - $25.1 $41,744 - $70,179	2,796 Added 3.87%	75,068 $1.84 Million
Q4 2018 Feb 08, 2019	BUY	$12.68 - $19.01 $71,489 - $107,178	5,638 Added 8.46%	72,272 $1.13 Million
Q3 2018 Oct 25, 2018	SELL	$13.1 - $16.35 $1,873 - $2,338	-143 Reduced 0.21%	66,634 $996,000
Q2 2018 Jul 30, 2018	BUY	$13.65 - $18.7 $911,506 - $1.25 Million	66,777 New	66,777 $972,000

494

67.2M

1.19M

829K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.41B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.